Chemo Fog

1. Short Introduction and History
Robert B. Raffa

2. Patient’s Perspective
Robert B. Raffa, Kathleen J. Martin

3. Oncology Nurse’s Perspective
Jamie S. Myers

4. Oncology Pharmacist’s Perspective
Rachel Clark-Vetri

5. The Impact of Chemo Brain on the Patient with a High-Grade Glioma
Michele R. Lucas

6. Neurocognitive Effects of Childhood Cancer Treatment
Jennifer Costa

7. The Economic Burden
Albert I. Wertheimer

8. Designing Conceptual Model-Based Research in Chemotherapy-Related Changes in Cognitive Function
Lisa M. Hess

9. Neuropsychologic Testing for Chemotherapy-Related Cognitive Impairment
Jamie S. Myers

10. Imaging as a Means of Studying Chemotherapy-Related Cognitive Impairment
Robert B. Raffa

11. Chemotherapy Associated Central Nervous System Damage
Jörg Dietrich

12. Is Systemic Anti-Cancer Therapy Neurotoxic? Does Chemo Brain Exist? And Should We Rename It?
Sophie Taillibert

13. Evaluation of Multiple Neurotoxic Outcomes in Cancer Chemotherapy
Bernard Weiss

14. Chemotherapy-Related Visual System Toxicity
Robert B. Raffa

15. The Possible Role of Cytokines in Chemotherapy-Induced Cognitive Deficits
Jamie S. Myers

16. Pharmacokinetics of Anti-Cancer Drugs Used in Breast Cancer Chemotherapy
Swati Nagar

17. Combination Analysis
Ronald J. Tallarida

18. Animal Models
Ellen A. Walker

19. Chemo Brain (Chemo Fog) as a Potential Side Effect of Doxorubicin Administration: Role of Cytokine-Induced, Oxidative/Nitrosative Stress in Cognitive Dysfunction
Christopher D. Aluise, Rukhsana Sultana, Jitbangjong Tangpong, Mary Vore, Daret St. Clair, Jeffrey A. Moscow, D. Allan Butterfield

20. Effects of 5-FU
Peter M. Wigmore, Sarah Mustafa, Maha El-Beltagy, Laura Lyons, Jariya Umka, Geoff Bennett

21. Future Directions
Robert B. Raffa, Ronald J. Tallarida

Avainsanat: Biomedicine, Biomedicine general, Cancer Research